Keywords: آنتاگونیست های مسکارینیک; Urinary bladder; Overactive; Muscarinic antagonists; Adrenergic beta-3 receptor agonists; OnabotulinumtoxinA;
مقالات ISI آنتاگونیست های مسکارینیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتاگونیست های مسکارینیک; muscarinic antagonists; cholinergic antagonists; urinary incontinence; medication adherence; patient compliance; IR; immediate release; MPR; medication possession rate; OAB; overactive bladder; RCT; randomized controlled trial; UI; urinary incontinence;
Keywords: آنتاگونیست های مسکارینیک; muscarinic antagonists; urinary bladder; overactive; fesoterodine; urinary incontinence; urge; vulnerable populationsAEs, adverse events; HRQL, health related quality of life; OAB, overactive bladder; PVR, post-void residual urinary volume; UUI, urgency u
Diagnóstico y tratamiento del paciente varón con sÃntomas del tracto urinario inferior en España - Estudio MERCURY. ¿Seguimos los urólogos las recomendaciones de las guÃas europeas?
Keywords: آنتاگونیست های مسکارینیک; SÃntomas del tracto urinario inferior; Alfabloqueante; Antagonistas muscarÃnicos; Calidad de vida relacionada con la salud; SÃntomas del tracto urinario en el varón; Lower urinary tract symptoms; Alpha-blocker; Muscarinic antagonists; Health-related q
Diagnosis and treatment of male patients with lower urinary tract symptoms in Spain - The MERCURY Study. Do urologists follow the recommendations of the European guidelines?
Keywords: آنتاگونیست های مسکارینیک; Lower urinary tract symptoms; Alpha-blocker; Muscarinic antagonists; Health-related quality of life; Urinary tract symptoms in men; SÃntomas del tracto urinario inferior; Alfabloqueante; Antagonistas muscarÃnicos; Calidad de vida relacionada con la salu
The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men
Keywords: آنتاگونیست های مسکارینیک; Benign prostatic hyperplasia; Erectile dysfunction; Lower urinary tract symptoms; Muscarinic antagonists; Phosphodiesterase 5 inhibitors; Phytotherapy;
Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension⢠Delivery Technology in patients with chronic obstructive pulmonary disease
Keywords: آنتاگونیست های مسکارینیک; COPD; Muscarinic antagonists; β2-agonist; Co-Suspension⢠Delivery Technology; Metered dose inhaler; AE; adverse event; BID; twice daily; CAT; COPD Assessment Test; COPD; chronic obstructive pulmonary disease; CI; confidence interval; DPI; dry powder in
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
Keywords: آنتاگونیست های مسکارینیک; β2-agonist; bronchodilator; chronic bronchitis; emphysema; muscarinic antagonists; AE; adverse event; ATS; American Thoracic Society; CAT; COPD Assessment Test; DPI; dry powder inhaler; FDC; fixed-dose combination; FEV1 AUC0-12; FEV1 area under the curv
Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD
Keywords: آنتاگونیست های مسکارینیک; Adherence; Beta-2 adrenergic agonists; Chronic obstructive pulmonary disease; Long-acting bronchodilators; Muscarinic antagonists; Onset of action;
Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients
Keywords: آنتاگونیست های مسکارینیک; Beta-2-agonists; Muscarinic antagonists; Acute myocardial infarction; Systematic review; Chronic obstructive pulmonary disease;
Safety and Tolerability of Solifenacin Add-on Therapy to α-Blocker Treated Men With Residual Urgency and Frequency
Keywords: آنتاگونیست های مسکارینیک; urinary bladder; overactive; muscarinic antagonists; adrenergic alpha-antagonists; AE; adverse event; BOO; bladder outlet obstruction; BPH; benign prostatic hyperplasia; EOT; end of treatment; I-PSS; International Prostate Symptom Score; LUTS; lower urina
Efficacy and Safety of Flexible Dose Fesoterodine in Men and Women with Overactive Bladder Symptoms Including Nocturnal Urinary Urgency
Keywords: آنتاگونیست های مسکارینیک; muscarinic antagonists; urinary bladder, overactive; nocturia; lower urinary tract symptoms; treatment outcomeESS, Epworth Sleepiness Scale; HRQL, health related quality of life; OAB, overactive bladder syndrome; OAB-q, overactive bladder questionnaire; U
Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators
Keywords: آنتاگونیست های مسکارینیک; COPD; Dynamic hyperinflation; Exercise tolerance; Short-acting β2-agonists; Long-acting; Muscarinic antagonists
Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms
Keywords: آنتاگونیست های مسکارینیک; Lower urinary tract symptoms; Prostatic hyperplasia; Adrenergic α1-receptor antagonists; 5α-reductase inhibitors; Muscarinic antagonists
Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups
Keywords: آنتاگونیست های مسکارینیک; Muscarinic antagonists; Inhaled; Airway disease; Solid phase synthesis; Quaternary ammonium salts;
The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms
Keywords: آنتاگونیست های مسکارینیک; urinary bladder; overactive; fesoterodine; muscarinic antagonists; placebo effect; dose-response relationship; drug; AE; adverse event; OAB; overactive bladder; PBO; placebo; PBO-E; placebo escalator group; PBO-NE; placebo nonescalator group; PPBC; Patien
Understanding Dose Titration: Overactive Bladder Treatment With Fesoterodine as an Example
Keywords: آنتاگونیست های مسکارینیک; Dose response; Fesoterodine; Muscarinic antagonists; Overactive bladder; Pharmacodynamic; Pharmacokinetic;
Fesoterodine: Individualised Treatment of Urgency Urinary Incontinence Across Patient Groups
Keywords: آنتاگونیست های مسکارینیک; Fesoterodine; Incontinence; Muscarinic antagonists; Overactive bladder; Urgency urinary incontinence;
Overactive Bladder Medication Adherence When Medication is Free to Patients
Keywords: آنتاگونیست های مسکارینیک; urinary bladder; overactive; muscarinic antagonists; delivery of health care; military personnel; medication adherenceER, extended release; IR, immediate release; MPR, medication possession ratio; OAB, overactive bladder
Spinal Effects of the Fesoterodine Metabolite 5-Hydroxymethyl Tolterodine and/or Doxazosin in Rats With or Without Partial Urethral Obstruction
Keywords: آنتاگونیست های مسکارینیک; prostatic hyperplasia; adrenergic alpha-antagonists; muscarinic antagonists; doxazosin; fesoterodineACh, acetylcholine; AR, adrenoceptor; BC, bladder catheterization; BCap, bladder capacity; BCom, bladder compliance; BP, baseline pressure; BPH, benign pro
A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder
Keywords: آنتاگونیست های مسکارینیک; receptors; neurokinin-1; tolterodine; muscarinic antagonists; urinary bladder; overactiveAE, adverse experience; ER, extended release; LS, least squares; NK-1R, neurokinin-1 receptor; OAB, overactive bladder; SP, substance P; TKs, tachykinins
Pharmacologic Therapy for the Neurogenic Bladder
Keywords: آنتاگونیست های مسکارینیک; Neurogenic urinary bladder; Muscarinic antagonists; Alpha-adrenergic antagonist; Imipramine; Spinal cord injury; Multiple sclerosis;
Safety and Tolerability of Solifenacin Add-on Therapy to α-Blocker Treated Men With Residual Urgency and Frequency
Keywords: آنتاگونیست های مسکارینیک; urinary bladder, overactive; muscarinic antagonists; adrenergic alpha-antagonistsAE, adverse event; BOO, bladder outlet obstruction; BPH, benign prostatic hyperplasia; EOT, end of treatment; I-PSS, International Prostate Symptom Score; LUTS, lower urinary
Efficacy and Safety of Transdermal and Oral Oxybutynin in Children With Neurogenic Detrusor Overactivity
Keywords: آنتاگونیست های مسکارینیک; muscarinic antagonists; oxybutynin; urinary catheterization; urinary incontinence; urodynamicsAE, adverse event; CIC, clean intermittent catheterization; DEO, N-desethyloxybutynin; ER, extended release; IR, immediate release; mITT, modified intent to trea
Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers
Keywords: آنتاگونیست های مسکارینیک; α-blockers; Overactive bladder; Muscarinic antagonists; Tolterodine
Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity
Keywords: آنتاگونیست های مسکارینیک; Bladder; Neurogenic; Child; Muscarinic antagonists; Urinary incontinence;
Effective Treatment of Neurogenic Detrusor Dysfunction by Combined High-Dosed Antimuscarinics without Increased Side-Effects
Keywords: آنتاگونیست های مسکارینیک; Detrusor-sphincter-dyssynergia; Neurogenic bladder; Muscarinic antagonists; Side-effects; Tolterodine; Trospium; Oxybutynin; Spinal cord injury
Increased Mental Slowing Associated With the APOE É4 Allele After Trihexyphenidyl Oral Anticholinergic Challenge in Healthy Elderly
Keywords: آنتاگونیست های مسکارینیک; APOE polymorphisms; anticholinergic challenge; muscarinic antagonists; memory; subjective ratings; elderly;
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives
Keywords: آنتاگونیست های مسکارینیک; Muscarinic antagonists; Affinity; Functional activity; 1,3-Oxathiolane sulfoxides
Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists
Keywords: آنتاگونیست های مسکارینیک; QSSR; CoMFA; Muscarinic antagonists; Subtype selectivity;
Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic Nerve
Keywords: آنتاگونیست های مسکارینیک; Bladder; Neurons; Afferent; Rats; Sprague-Dawley; Muscarinic antagonists; Darifenacin
Structure–activity relationships of methoctramine-related polyamines as muscarinic antagonist: Effect of replacing the inner polymethylene chain with cyclic moieties
Keywords: آنتاگونیست های مسکارینیک; Methoctramine; Polyamines; Muscarinic antagonists; Pain
Case Series Data to Encourage Randomized Trials of Bladder Retraining Compared to Antimuscarinic Agents
Keywords: آنتاگونیست های مسکارینیک; urinary incontinence; muscarinic antagonists; treatment outcomeCI, confidence interval; ΔInc, change in incontinence; OAB, overactive bladder
Overactive Bladder: A Better Understanding of Pathophysiology, Diagnosis and Management
Keywords: آنتاگونیست های مسکارینیک; bladder; urinary incontinence; muscarinic antagonists; behavioral medicineACh, acetylcholine; BTX, botulinum toxin A; CNS, central nervous system; ICI, International Consultation on Incontinence; ICS, International Continence Society; LUT, lower urinary t
Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3
Keywords: آنتاگونیست های مسکارینیک; Chiral benzilic acid derivatives; Muscarinic antagonists; Muscarinic receptors (M1, M2, M3); Molecular modelling; 4-DAMP; 4-diphenylacetoxy-N-methylpiperidine methiodide; E; extracelluar loop; EL; energy of the isolated ligand; ER; energy of the empty rec
IS THERE A ROLE FOR ANTIMUSCARINICS IN RENAL COLIC? A RANDOMIZED CONTROLLED TRIAL
Keywords: آنتاگونیست های مسکارینیک; kidney; colic; calculi; butylscopolammonium bromide; muscarinic antagonists;
CHANGES IN OVERACTIVE BLADDER SYMPTOMS AFTER DISCONTINUATION OF SUCCESSFUL 3-MONTH TREATMENT WITH AN ANTIMUSCARINIC AGENT: A PROSPECTIVE TRIAL
Keywords: آنتاگونیست های مسکارینیک; bladder; urinary incontinence; muscarinic antagonists; propiverine;
USE OF TOLTERODINE IN CHILDREN WITH NEUROGENIC DETRUSOR OVERACTIVITY: RELATIONSHIP BETWEEN DOSE AND URODYNAMIC RESPONSE
Keywords: آنتاگونیست های مسکارینیک; child; drug therapy; bladder, neurogenic; muscarinic antagonists;
COMBINED USE OF α-ADRENERGIC AND MUSCARINIC ANTAGONISTS FOR THE TREATMENT OF VOIDING DYSFUNCTION
Keywords: آنتاگونیست های مسکارینیک; bladder; prostate; adrenergic alpha-antagonists; muscarinic antagonists; urination disorders
TOLTERODINE TREATMENT FOR CHILDREN WITH SYMPTOMS OF URINARY URGE INCONTINENCE SUGGESTIVE OF DETRUSOR OVERACTIVITY: RESULTS FROM 2 RANDOMIZED, PLACEBO CONTROLLED TRIALS
Keywords: آنتاگونیست های مسکارینیک; child; drug therapy; urinary incontinence; muscarinic antagonists;